SCHEMBL16612853

SCHEMBL16612853

COc1cc(OC)c2cc[nH]c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
DYRK1A Q13627 2/20 0.39
CLK1 P49759 1/20 0.39
CLK2 P49760 1/20 0.39
CLK3 P49761 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
CHEK1 O14757 1/20 0.36
ATR Q13535 1/20 0.36
PDCD1 Q15116 1/20 0.36
ATRIP Q8WXE1 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TTK P33981 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1835480 0.84 BRD4 (0.42) BRD4DYRK1ATTKTNNI3KADORA1
SCHEMBL23147921 0.82 BRD4 (0.43) BRD4DYRK1ATTKTLR8TLR7
SCHEMBL29721888 0.82 BRD4 (0.43) BRD4DYRK1ATTKTLR8TLR7
SCHEMBL3360828 0.81 PRKCI (0.44) BRD4DYRK1ACLK1CLK2CLK3
SCHEMBL23148049 0.81 AXL (0.44) BRD4DYRK1ACLK1CLK2CLK3
SCHEMBL29722091 0.81 TRPA1 (0.38) BRD4DYRK1ACLK1CLK2CLK3
SCHEMBL23147607 0.81 TRPA1 (0.38) BRD4DYRK1ACLK1CLK2CLK3
SCHEMBL29954439 0.77 ALDH1A1 (0.38) BRD4KDM4EALDH1A1DYRK1ACLK1
SCHEMBL22759057 0.71 EGFR (0.35) BRD4DYRK1ACLK1CLK2CLK3
SCHEMBL298491 0.70 BRD4 (0.60) BRD4DYRK1ACLK2CDK5CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP disclosed